CVS CEO Joyner touts 'cautious and prudent' approach after stock gains 15% following earnings beat
CEO David Joyner's conservative approach to the company's 2025 financial outlook, rewarding the stock with a nearly 15% bump by market close Wednesday. Joyner also used the opportunity to defend his ...
Leerink upgrades CVS Health to Outperform, sees ‘positively skewed’ reward
Leerink analyst Michael Cherny upgraded CVS Health (CVS) to Outperform from Market Perform with a price target of $75, up from $55. The firm ...
CVS CEO Joyner: 'No one has demonstrated more success than the PBMs'
CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...
Managed Healthcare Executive4h
David Joyner: CVS Health is on a Pharmacy Transformation Journey
Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...
Fierce Healthcare5h
CVS CEO Joyner mounts defense of PBM industry amid ongoing scrutiny
CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...
CVS CEO defends pharmacy middlemen, accuses drugmakers of ‘monopolistic' practices
CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...
CVS exec blasts drugmakers and defends PBMs
When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday.
The Caledonian Record11h
CVS Health steers through rising insurance costs in a strong fourth quarter
CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...